RTO.LRentokil Initial plc
The schedule
- Thu22Oct
Q3 2026 Trading Update assessing North American organic growth stabilization and Terminix synergy realization.
- Thu4Mar
FY 2026 Earnings Print and initial 2027 margin guidance, representing a critical test for the Terminix acquisition thesis.
- Thu22Apr
Q1 2027 Trading Update providing an early read on the spring pest control season and market share retention.
- Tue27Jul
H1 2027 Earnings Release with detailed mid-year updates on operating cash flow conversion and debt reduction.
Past
- Tue28Jul
Actual outcome: Bear · $360.30 at outcome
Rentokil Initial reported H1 2026 EPS exactly in-line with estimates at 0.0834. Although the stock saw a minor 2.9% uptick following the print, it remained trapped below the $450 bear floor as investors focused on sluggish North American organic growth and slower-than-anticipated Terminix synergy realization. The lack of a meaningful upside catalyst in these key operational areas prevented a broader recovery, keeping overall price action in bearish territory.
Rentokil Initial reported H1 2026 EPS exactly in-line with estimates at 0.0834. Although the stock saw a minor 2.9% uptick following the print, it remained trapped below the $450 bear floor as investors focused on sluggish North American organic growth and slower-than-anticipated Terminix synergy realization. The lack of a meaningful upside catalyst in these key operational areas prevented a broader recovery, keeping overall price action in bearish territory.